Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.420 | ||
| Révision: | $364.24M | $331.67M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.030 | -0.040 | -1.0700 |
| Révision: | $337.81M | $336.72M | -$77.15M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.400 | 1.150 | -0.2500 |
| Révision: | $321.95M | $395.19M | $7.57M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.080 | 0.710 | -0.3700 |
| Révision: | $314.81M | $345.24M | -$16.75M |
